SamuelLentzMD

Obstetrics & Gynecology • Winston Salem, NC

Gynecologic Oncology, Urogynecology & Pelvic Reconstructive Surgery

Professor of Obstetrics & Gynecology, Wake Forest University

Join to view full profile

Dr. Lentz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lentz's full profile

Already have an account?

Office
500 Shepherd St
Winston Salem, NC 27103
Phone+1 336-716-2255

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Residency, Obstetrics and Gynecology, 1986 - 1989
Wake Forest University Baptist Medical CenterInternship, Transitional Year, 1978 - 1979
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978

Certifications & Licensure

NC State Medical License 1979 - 2024
MN State Medical License 1986 - 1989
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Female Pelvic Medicine and Reconstructive Surgery
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2018
America's Top Doctors for Cancer Castle Connolly, 2005-2018
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Top MD Consumers Checkbook
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery Start of enrollment: 2012 Jun 04
Terminated
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Trial Evaluating Feasibility and Quality of Life of Second Look Laparoscopy With Hyperthermic Intraperitoneal Chemotherapy Start of enrollment: 2021 May 20
Recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

923 citations
A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelv...
Alexander Sedlis, Brian N. Bundy, Marvin Rotman, Samuel S. Lentz, Laila I. Muderspach
Gynecologic Oncology. 1999-05-01
437 citations
Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Onc...
Franco M. Muggia, Patricia S. Braly, Mark F. Brady, Gregory P. Sutton, Theodore H. Niemann
Journal of Clinical Oncology. 2000-01-01
173 citations
A Phase II Trial of Paclitaxel in Patients with Advanced or Recurrent Adenocarcinoma of the Endometrium: A Gynecologic Oncology Group Study
Harrison Ball, John A. Blessing, Samuel S. Lentz, David G. Mutch
Gynecologic Oncology. 1996-08-01

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow